BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Atara Biotherapeutics Appoints Cell Therapy and Oncology Commercialization Veteran Ameet Mallik to the Board of Directors

  Atara Biotherapeutics, Inc., a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, announced the appointment of Ameet Mallik to the Board of Directors.

  August 9, 2021

   · 

  5 min read
• Business

  INOVIO Reports Second Quarter 2021 Financial Results

  INOVIO, a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases, reported financial results for the quarter ended June 30, 2021.

  August 9, 2021

   · 

  25 min read
• Business

  Gossamer Bio Announces Second Quarter 2021 Financial Results and Provides Corporate Update

  Gossamer Bio, Inc., a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, announced its financial results for the second quarter of 2021 and provided a corporate update.

  August 9, 2021

   · 

  9 min read
• Business

  Omeros Corporation Reports Second Quarter 2021 Financial Results

  Omeros Corporation (Nasdaq: OMER), today announced recent highlights and developments as well as financial results for the second quarter ended June 30, 2021.

  August 9, 2021

   · 

  11 min read
• Business

  Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2021

  Amphastar Pharmaceuticals, Inc. today reported results for the three months ended June 30, 2021.

  August 9, 2021

   · 

  17 min read
• Business

  Celcuity Inc. Reports Second Quarter 2021 Financial Results and Provides Corporate Update

  Celcuity today announced financial results for the second quarter ended June 30, 2021 and summarized recent business progress.

  August 9, 2021

   · 

  13 min read
• Business

  Kaleido Biosciences Announces New Chairperson Appointment to its Board of DirectorsCurrent Director Theo Melas-Kyriazi appointed Chairperson of the Board of Directors

  Kaleido Biosciences, Inc. today announced the appointment of current Board member Theo Melas-Kyriazi as Chairperson of the Board of Directors effective August 9, 2021.

  August 9, 2021

   · 

  4 min read
• Business

  Castle Biosciences Announces Second Quarter 2021 Results

  Castle Biosciences, Inc. today announced its financial results for the second quarter and six months ended June 30, 2021.

  August 9, 2021

   · 

  24 min read
• Business

  Vapotherm Reports Second Quarter 2021 Financial Results

  Vapotherm, Inc. today announced second quarter 2021 financial results.

  August 9, 2021

   · 

  18 min read
• Business

  Pulse Biosciences Reports Second Quarter 2021 Financial Results

  Pulse Biosciences, Inc. today announced financial results for the second quarter of 2021.

  August 9, 2021

   · 

  14 min read